CIK 0001636651
- Non-accelerated filer
- Smaller reporting company
Ovid Therapeutics Inc.
Sign in to watch- Ticker
- OVID
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 465270895
- Phone
- +1 212-776-4381
- Business address
- 441 NINTH AVENUE, 14TH FLOOR, NEW YORK, NY, 10001
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-12-08 | TAKEDA PHARMACEUTICAL CO LTD 10% owner | Conversion | +1,250,000 | 7,000,000 | ||
| 2025-12-08 | TAKEDA PHARMACEUTICAL CO LTD 10% owner | Conversion · Series A Convertible Preferred Stock | −1,250 | 0 | ||
| 2022-07-01 | TAKEDA PHARMACEUTICAL CO LTD 10% owner | Other disposition | −5,750,000 | 0 | ||
| 2022-07-01 | TAKEDA PHARMACEUTICAL CO LTD 10% owner | Other acquisition | +5,750,000 | 5,750,000 | ||
| 2022-07-01 | TAKEDA PHARMACEUTICAL CO LTD 10% owner | Other disposition · Series A Convertible Preferred Stock | −1,250 | 0 | ||
| 2022-07-01 | TAKEDA PHARMACEUTICAL CO LTD 10% owner | Other acquisition · Series A Convertible Preferred Stock | +1,250 | 1,250 | ||
| 2019-10-08 | TAKEDA PHARMACEUTICAL CO LTD 10% owner | Purchase | +2,000,000 | $2.50 | $5.0M | 5,750,000 |
Page 1 of 1 · 7 trades